![WMBF News](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/710/normal/Screen_Shot_2016-01-26_at_15.11.39.png?1453821128)
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WMBF News,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Information contained on this page is provided by an independent third-party content provider.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
/PRNewswire-USNewswire/ -- The Emmes Corporation today announced that Dr. Paul VanVeldhuisen, chief operating officer and…
Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators News provided by 08:30 ET Share this article ROCKVILLE, Md.
Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md., May 17, 2017 /PRNewswire-USNewswire/ -…
NEW YORK (Reuters Health) - Bevacizumab is as effective as aflibercept for improving visual acuity in patients with macular…
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
NIH’s National Eye Institute (NEI) reported that intravitreal Avastin bevacizumab was non-inferior to Eylea aflibercept on the…
NIH’s National Eye Institute (NEI) reported that intravitreal Avastin bevacizumab was non-inferior to Eylea aflibercept on the…
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Highlights Central retinal vein occlusion (CRVO) occurs when the vein carrying the blood flow to the retina is blocked.
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Return to Article List Use of either drug improved vision and had few side effects Article ID: 674326 Released: 8-May-2017 11:15…
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
NIH-funded clinical trial shows use of either drug improved vision and had few side effects.
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…